SPDR SP Financials
| XPH Etf | USD 46.57 0.23 0.50% |
Net Expense Ratio 0.0035 | 3 y Sharp Ratio (0.12) |
SPDR |
The data published in SPDR SP's official financial statements typically reflect SPDR SP's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving SPDR SP's quantitative information. For example, before you start analyzing numbers published by SPDR accountants, it's essential to understand SPDR SP's liquidity, profitability, and earnings quality within the context of the SPDR State Street Global Advisors space in which it operates.
SPDR SP Etf Summary
SPDR SP competes with Global X, Global X, Global X, and Global X. In seeking to track the performance of the SP Pharmaceuticals Select Industry Index , the fund employs a sampling strategy. SP Pharmaceuticals is traded on NYSEARCA Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NYSE ARCA Exchange |
| ISIN | US78464A7220 |
| CUSIP | 78464A722 86330E596 |
| Region | North America |
| Investment Issuer | SSgA |
| Etf Family | SPDR State Street Global Advisors |
| Fund Category | Sector |
| Portfolio Concentration | Health Care |
| Benchmark | Dow Jones Industrial |
| Phone | NA |
| Currency | USD - US Dollar |
SPDR SP Key Financial Ratios
SPDR Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SPDR SP's current stock value. Our valuation model uses many indicators to compare SPDR SP value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SPDR SP competition to find correlations between indicators driving SPDR SP's intrinsic value. More Info.SPDR SP Pharmaceuticals is rated first in price to earning as compared to similar ETFs. It is rated first in price to book as compared to similar ETFs fabricating about 0.23 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for SPDR SP Pharmaceuticals is roughly 4.34 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SPDR SP's earnings, one of the primary drivers of an investment's value.SPDR SP Pharmaceuticals Systematic Risk
SPDR SP's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. SPDR SP volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on SPDR SP Pharmaceuticals correlated with the market. If Beta is less than 0 SPDR SP generally moves in the opposite direction as compared to the market. If SPDR SP Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one SPDR SP Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of SPDR SP is generally in the same direction as the market. If Beta > 1 SPDR SP moves generally in the same direction as, but more than the movement of the benchmark.
About SPDR SP Financials
What exactly are SPDR SP Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include SPDR SP's income statement, its balance sheet, and the statement of cash flows. Potential SPDR SP investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although SPDR SP investors may use each financial statement separately, they are all related. The changes in SPDR SP's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on SPDR SP's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.SPDR SP Thematic Clasifications
SPDR SP Pharmaceuticals is part of several thematic ideas from Sector ETFs to Health Care ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasSPDR SP November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of SPDR SP help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of SPDR SP Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of SPDR SP Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing SPDR Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build SPDR SP's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.14 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 4.92 | |||
| Value At Risk | (1.71) | |||
| Potential Upside | 1.87 |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Pharmaceuticals. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
The market value of SPDR SP Pharmaceuticals is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.